|
ZBTB5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
8.62132587542419E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
3.643600E-01 |
| Stage1-vs-Stage3 |
5.504100E-02 |
| Stage1-vs-Stage4 |
1.598250E-03 |
| Stage2-vs-Stage3 |
4.318400E-02 |
| Stage2-vs-Stage4 |
7.439600E-03 |
| Stage3-vs-Stage4 |
2.208200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
9.79169967330051E-10 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
5.093000E-01 |
| Caucasian-vs-Asian |
7.361600E-01 |
| AfricanAmerican-vs-Asian |
3.940200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
8.360400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
1.62702999999542E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.303400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.665800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.967600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.671000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.272600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.526000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.21990000001571E-06 |
| Classical-VS-Follicular |
5.193600E-01 |
| Classical-VS-Other |
9.444800E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.404700E-04 |
| Tall-VS-Other |
3.411200E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
7.872800E-01 |
| Follicular-VS-Normal |
1.66922031752392E-12 |
| Other-VS-Normal |
8.13860000000721E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.571950E-02 |
|
|
